Tirofiban Hydrochloride Injection
Product Images NDC 14789-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tirofiban Hydrochloride (NDC 14789-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tir00 0010 01)

FDA Label Image

Figure (Tir00 0010 02)

FDA Label Image

Figure (Tir00 0010 03)

FDA Label Image

Figure (Tir00 0010 04)

FDA Label Image

Figure (Tir00 0010 05)

FDA Label Image

Figure 1 (Tir00 0010 06)

FDA Label Image

Principal Display Panel – 100 mL Carton Label (Tir00 0010 07)

Principal Display Panel – 100 mL Carton Label (Tir00 0010 07)
This text appears to be a description of a medication called Tirofiban Hydrochloride Injection. It is recommended to protect the medication from light during storage and to use it with a calibrated infusion device. It is a premixed injection and comes in a single-dose container. Each 100 mL contains Tirofiban hydrochloride equivalent to 5 mg of tirofiban. The medication should be stored at a temperature between 15 to 30°C (50°F to 86°F). It is manufactured by Nexus Pharmaceutical, Inc. in the UK.*
FDA Label Image

Principal Display Panel – 100 mL Bag Label (Tir00 0010 08)

Principal Display Panel – 100 mL Bag Label (Tir00 0010 08)
This is a description for Tirofiban Hydrochloride Injection, a medication that is recommended for use with a calibrated infusion device. It comes in a 100 mL single-dose container and is only available with a prescription. The injection contains 5mg of Tirofiban hydrochloride per 100 mL, with a concentration of 50 mcg/mL. The solution is pre-mixed, iso-osmotic, sterile, and non-pyrogenic. It also contains sodium chloride, sodium citrate dihydrate, citric acid monohydrate, and water for injection. The pH of the solution can be adjusted with hydrochloric acid and/or sodium hydroxide. The usual dosage of this medication is intravenously, as directed by a physician. It is important not to add any supplementary medication to the injection. The bag should be checked for minute leaks by squeezing it firmly, and if any leaks are found, the bag should be discarded as it may affect the sterility of the solution. It is also advised not to use this medication in series connections. Additionally, the solution should only be used if it is clear. The recommended storage temperature for this medication is between 15°C to 30°C (59°F to 86°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It should not be frozen and should be protected from light during storage. The medication is manufactured in the UK for Nexus Pharmaceutical, Inc., located in Lincolnshire, IL, USA. The text does not provide information about the lot or expiration date.*
FDA Label Image

Principal Display Panel – 250 mL Carton Label (Tir00 0010 09)

FDA Label Image

Principal Display Panel – 250 mL Bag Label (Tir00 0010 10)

Principal Display Panel – 250 mL Bag Label (Tir00 0010 10)
Recommended for use with a calibrated infusion device, this product is a 250 mL single-dose container of Tirofiban Hydrochloride Injection. It contains 12.5mg of Tirofiban per 250 mL, with a concentration of 50 mcg/mL. This pre-mixed solution is iso-osmotic, sterile, and non-pyrogenic. It also contains sodium chloride, sodium citrate dihydrate, citric acid monohydrate, and water for injection. The solution's pH can be adjusted with hydrochloric acid and/or sodium hydroxide. It is intended for intravenous use as directed by a physician. Care should be taken not to add supplementary medication, and any leaks should be checked for and the bag discarded if found. It should not be used in series connections and should only be used if the solution is clear. The recommended storage temperature is between 15°C to 30°C (59°F to 86°F), with excursions permitted up to 25°C (77°F). It should be protected from freezing and light during storage. Manufactured by Nexus Pharmaceuticals, LLC in Lincolnshire, IL, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.